Last updated on 30 Apr 2024
Owner Info
Revance Therapeutics, Inc.
7555 Gateway Blvd.
Newark CA 94560, UNITED STATES OF AMERICA
Serial Number
2174657 filed on 10 Feb 2021
Correspondent
Maren C. Perry King & Spalding LLP
1185 Avenue of the Americas,
New York NY 10036,
UNITED STATES OF AMERICA
2174657
10 Feb 2021
NA
FIGURATIVE
29 Sept 2020
US
Status Date | Action Taken |
---|---|
30th Apr 2024 | Status change to Voided |
1st Jun 2023 | International Registration in Australia Protected After Adverse (No amendments) correspondence sent |
31st May 2023 | International Registration in Australia Protected After Adverse (No amendments) correspondence sent |
31st May 2023 | IP Right Registration Published |
31st May 2023 | Status change to Registered/Protected |
24th Mar 2023 | Application Accepted correspondence sent |
23rd Mar 2023 | Application Accepted correspondence sent |
23rd Mar 2023 | IP Right has been Examined |
23rd Mar 2023 | IP Right Acceptance Published |
23rd Mar 2023 | Status change to Accepted |